37 studies found for:    " October 07, 2009":" November 06, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Pilot Study of Text Message Reminders to Improve HIV Medication Adherence in Botswana
Condition: HIV Infections
Intervention: Other: Cell phone text message
22 Completed Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV
Condition: HIV Infections
Intervention: Drug: Raltegravir
23 Completed Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
Conditions: Malaria;   HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Zidovudine;   Drug: Lamivudine
24 Completed
Has Results
Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease
Conditions: HIV Infections;   Heart Disease
Interventions: Drug: Lovaza;   Drug: Placebo
25 Completed Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens
Conditions: HIV Infections;   Adherence
Intervention:
26 Completed
Has Results
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
Conditions: HIV Infection;   Hepatitis C Infection
Interventions: Drug: Nitazoxanide (NTZ);   Drug: Pegylated interferon alfa-2a (PEG);   Drug: Ribavirin (RBV)
27 Completed Ritonavir-boosted Lopinavir Monotherapy
Condition: HIV
Intervention: Drug: lopinavir/ritonavir soft gel capsule
28 Completed
Has Results
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Drug: maraviroc;   Drug: darunavir;   Drug: ritonavir
29 Completed Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1
Condition: HIV-1 Infections
Intervention: Drug: BMS-663068 with or without ritonavir
30 Active, not recruiting CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients
Condition: HIV-1 Infections
Interventions: Drug: IL-2 (~1.2M IU/m2);   Biological: T Cell infusion 5-10 x E9 T cells
31 Completed Managerial Database II
Condition: HIV
Intervention: Other: Observation
32 Active, not recruiting Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Atazanavir/Ritonavir;   Drug: Tenofovir/Emtricitabine
33 Completed Durability of Adherence in Self-Management of HIV (The DASH Study)
Condition: HIV Infections
Intervention: Behavioral: Modified client adherence profiling and intervention tailoring (CAP-IT)
34 Completed
Has Results
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
Conditions: HIV Infections;   H1N1 Influenza Virus
Intervention: Biological: Influenza A (H1N1) monovalent vaccine
35 Completed Support To Reunite Involve and Value Each Other
Conditions: Family Relations;   Runaway Behavior;   Risky Sexual Behavior;   Substance Use
Intervention: Behavioral: STRIVE family intervention
36 Completed Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Methemoglobinemia;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Nonmalignant Neoplasm
Interventions: Drug: chemotherapy;   Drug: dapsone;   Other: medical chart review;   Procedure: assessment of therapy complications
37 Completed
Has Results
H1N1 Vaccine at Two Dose Levels in HIV Positive Adults
Condition: Influenza
Intervention: Biological: Inactivated Influenza H1N1 vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Indicates status has not been verified in more than two years